Optimizing Micafungin Dosing in Patients with Critically Ill Candidemia and Trends of Candida Species Causing Bloodstream Infections in a Tertiary Hospital in Thailand: A Monte Carlo Simulation Approach
Non-<i>albicans Candida</i> bloodstream infections are increasing, along with higher MIC trends, signaling emerging resistance. Standard dosing may be insufficient in critically ill patients. Empirical high-dose micafungin could improve treatment efficacy.
Authors
- Adisak Sangchankoom
- Worawong Chueansuwan
- Weerayuth Saelim (ORCID: https://orcid.org/0000-0001-5839-440X)
- Piraporn Juntanawiwat (ORCID: https://orcid.org/0000-0002-8543-8428)
- Nuntra Suwantarat (ORCID: https://orcid.org/0000-0002-9356-2592)
- Wichai Santimaleeworagun
- Jutharat Watcharasuwanseree
Institutions
- Thammasat University (TH)
- Thammasat University Hospital (TH)
- Hodges University (US)
- Phramongkutklao Hospital (TH)
- Suratthani Cancer Hospital (TH)
- Udon Thani Hospital (TH)
- Silpakorn University (TH)
Publication Details
- Journal
- Drug Design Development and Therapy
- Published
- 2025-10-01
- DOI
- https://doi.org/10.2147/dddt.s549066
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Thammasat University